Clinical Trials Logo

Clinical Trial Summary

The investigators are conducting a Type I hybrid effectiveness-implementation trial to assess the effectiveness of HINT-S (synchronous) compared to enhanced usual care (EUC) in promoting health insurance literacy, thus reducing worry, unmet health care needs, and financial consequences due to medical costs to improve care and long-term outcomes of childhood cancer survivors. The investigators will also compare HINT-S to HINT-A (asynchronous), a prerecorded, asynchronous version of the 5 HINT-S navigator sessions.


Clinical Trial Description

The present study seeks to evaluate a health insurance navigation program with childhood cancer survivors recruited from the Long-Term Follow-Up (LTFU) Cohort. Childhood cancer survivors face health challenges throughout their lives that require monitoring and ongoing care. This is compounded by the tendency among childhood survivors to have higher rates of underinsurance, unmet healthcare needs, and burdensome costs related to care. These burdensome costs also contribute to underutilization of care among survivors. Dr. Park and her colleagues published findings that suggested LTFU survivors had difficulty in understanding how to use their insurance, and often experienced financial-related distress. Understanding and navigating insurance benefits in the current landscape is crucial for cancer survivors to obtain and utilize the health care that they need. With this in mind, the study investigators propose to evaluate the effectiveness of an insurance navigation intervention with LTFU participants, delivered in a synchronous and asynchronous modality. The navigation intervention will be delivered by a health insurance navigator via HIPAA-compliant videoconferencing for the synchronous group (HINT-S) and will be delivered via pre-recorded video session for the asynchronous group HINT-A). Participants will be randomized into either the two navigation intervention arms (HINT-S and HINT-A; approximately 234 per intervention arm), or the enhanced usual care arm (approximately 52 for control arm). The sample size per arm was chosen to enable evaluation of feasibility and acceptability goals, as well as to explore meaningful differences in the outcomes. To assess the proposed primary and secondary outcomes, all trial participants will complete a baseline and 6-month and 12-month post-program follow-up survey. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05527392
Study type Interventional
Source Massachusetts General Hospital
Contact Elyse R Park, PhD
Phone 617-724-6836
Email epark@mgh.harvard.edu
Status Recruiting
Phase N/A
Start date May 1, 2023
Completion date April 1, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT05562193 - Exercise and Pain in CCS N/A
Withdrawn NCT01948232 - Pilot Study of Perindopril in Childhood Cancer Survivors Phase 2
Completed NCT04075734 - Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors N/A
Completed NCT05641636 - Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors
Recruiting NCT02355340 - Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
Completed NCT04947709 - Physical Activity Post-Cancer for Adolescents and Young Adults N/A
Completed NCT04520061 - Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer N/A
Recruiting NCT03523377 - Overnight Fasting After Completion of Therapy: The OnFACT Study N/A
Recruiting NCT05463796 - InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer